Stryker Corporation management check

SYK · Health Care · Health Care Equipment · CEO Mr. Lobo

Filings as of

71
Management score, ranked 162nd of 487 · 18th of 60 in Health Care5 good · 2 to watch · 0 flaggedStrongest: clean books · Weakest: dilution · Best and worst run in Health Care →

The seven checks

  • Good

    Have owners done well?

    Beat its chosen peersOwners$151Peers$148

    What $100 became since fiscal 2021

    5256th
    Detail

    $100 invested at the start of fiscal 2021 grew to $151, against $148 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    8146th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.61 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Good

    What does the CEO cost owners?

    0.7% of net income

    $21.4m pay · $3.2bn net income, FY2025

    0.1%1%3%10%
    6566th
    Detail

    $21.4m of reported pay in fiscal 2025, against $3.2bn of net income.

  • Watch

    Do they own the stock?

    Insiders are selling

    6 mo: ▲ $0 bought · ▼ $395.3m sold

    ——
    Detail

    4 insiders sold $395.3m in the last six months and none bought. 6 of 40 sales ran on pre-arranged 10b5-1 plans.

  • Watch

    Are owners being diluted?

    Share count growing2021 · 382m2025 · 387m

    Diluted shares +0.4% a year; flagged above +2%

    0%10%20%

    Stock pay 1.0% of revenue

    4527th
    Detail

    Diluted shares changed +0.4% a year over the last three fiscal years. Stock-based pay was 1.0% of revenue in the latest year.

  • Good

    Is leadership stable?

    8 leadership filings in 3 years

    8 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Mr. Lobo

    8562nd
    Detail

    CEO in the pay table: Mr. Lobo. 8 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed March 23, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$24.1m$48.2m$10020212022202320242025$151$148

Pay tied most to reported net sales growth

Other key measuresReported net sales growthConstant currency salesAdjusted net earnings per diluted share growthAdjusted operating incomeAdjusted operating income margin

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Mr. Lobo$21.4m$24.8m$4.6m$151$148$3.2bn
2024—$22.0m$48.2m$6.4m$153$129$3.0bn
2023—$20.8m$42.5m$6.1m$126$126$3.2bn
2022—$18.6m$11.4m$5.2m$102$124$2.4bn
2021—$16.4m$27.8m$5.8m$110$126$2.0bn

Insiders and the CEO's stakeSelling

4 insiders sold $395.3m in the last six months and none bought. 6 of 40 sales ran on pre-arranged 10b5-1 plans.

Open-market trades by officers and directors since May 21, 2026.

  • SoldRonda E StrykerDirector$393.5mNov 6, 2026
  • SoldRobert S FletcherVP, Chief Legal Officer · 10b5-1 plan$1.4mMay 28, 2026
  • SoldDebra KingSee Remarks$278kAug 18, 2026
  • SoldDylan Bram CrottyGroup President$145kAug 21, 2026

Leadership and governance on file

20222023202420252026Leadership 8Votes 5
All 8 filings

Latest shareholder vote results: May 8, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $5.6bn returned to owners in buybacks and dividends, 41% of net income, and $1.0bn of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$1.6bn$3.2bn20212022202320242025Shares382m382m384m386m387m
Show the figures
Fiscal year20212022202320242025
Revenue$17.1bn$18.4bn$20.5bn$22.6bn$25.1bn
Net income$2.0bn$2.4bn$3.2bn$3.0bn$3.2bn
Stock-based pay$171.0m$168.0m$205.0m$229.0m$243.0m
Buybacks$0————
Dividends$950.0m$1.1bn$1.1bn$1.2bn$1.3bn
Diluted shares382m382m384m386m387m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.